SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $226,000 | -14.4% | 8,632 | -31.9% | 0.01% | -28.6% |
| Q3 2020 | $264,000 | +6.9% | 12,679 | +22.3% | 0.01% | +75.0% |
| Q2 2020 | $247,000 | +2.9% | 10,370 | +43.4% | 0.00% | -42.9% |
| Q4 2018 | $240,000 | -79.2% | 7,230 | -71.3% | 0.01% | -61.1% |
| Q1 2018 | $1,154,000 | +48.3% | 25,193 | +29.1% | 0.02% | +80.0% |
| Q4 2017 | $778,000 | -49.7% | 19,512 | -49.5% | 0.01% | -52.4% |
| Q3 2017 | $1,546,000 | +3.5% | 38,654 | +11.6% | 0.02% | +16.7% |
| Q2 2017 | $1,493,000 | +28.0% | 34,642 | -7.0% | 0.02% | +28.6% |
| Q1 2017 | $1,166,000 | -6.1% | 37,268 | -24.2% | 0.01% | +16.7% |
| Q4 2016 | $1,242,000 | +307.2% | 49,188 | +229.1% | 0.01% | +300.0% |
| Q2 2016 | $305,000 | +26.6% | 14,948 | -16.6% | 0.00% | -50.0% |
| Q4 2015 | $241,000 | +73.4% | 17,921 | +11.9% | 0.01% | 0.0% |
| Q3 2014 | $139,000 | – | 16,021 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |